adjuvanted quadrivalent influenza vaccine
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for adjuvanted quadrivalent influenza vaccine, covering 2023-09-28 to 2023-09-28. Get the full timeline:
Most recent: Clinical Trial Update: A Clinical Study to Evaluate the Immunogenicity and Safety of an Adjuvanted Quadrivalent Influenza Vaccine Compared With a Licensed Quadrivalent Vaccine in Adults 50 to 64 Years of Age [Phase 3]